ANI Pharmaceuticals, Inc. is a diversified bio-pharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products.

RECENT NEWS

ANI Pharmaceuticals Announces Intent to Appeal Rulings in CG Oncology Matter

2026-07-16

READ MORE >

ANI Pharmaceuticals Announces Positive Six-Month Topline Data from the Phase 4 Open-Label, Single-Arm SYNCHRONICITY Trial Evaluating Fluocinolone Acetonide Intravitreal Implant in Patients with Chronic Non-Infectious Uveitis

2026-07-13

READ MORE >

NASDAQ - ANIP

$79.20

0 ( 0% )

Pricing delayed by 20 minutes
Last updated